Group 1 - The announcement states that the Shanghai Stock Exchange has approved Donghai Securities Co., Ltd. to provide primary market-making services for the E Fund CSI Dividend ETF (100 Dividend, fund code: 515180) starting from January 8, 2026, to enhance market liquidity and stable operation [1][2][3]

Group 1 - The core point of the announcement is the approval for Donghai Securities Co., Ltd. to provide primary market-making services for the Huaxia SSE Sci-Tech Innovation Board Comprehensive Index Securities Investment Fund starting from January 8, 2026 [1][2][3] Group 2 - The purpose of this approval is to enhance the market liquidity and stable operation of the Sci-Tech Innovation Index Fund [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 为促进易方达上证50交易型开放式指数证券投资基金（以下简称SZ50ETF，基金代码:510100）的 市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上市基金做市业 务》等相关规定，本所同意东海证券股份有限公司自2026年01月08日起为SZ50ETF提供主做市服务。 特此公告。 上海证券交易所 2026年01月07日 上证公告（基金）【2026】22号 ...

为促进华宝沪深300增强策略交易型开放式指数证券投资基金（以下简称300ETF增，基金代 码:562070）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意东海证券股份有限公司自2026年01月08日起为300ETF增提供 主做市服务。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 上证公告（基金）【2026】23号 上海证券交易所 2026年01月07日 特此公告。 ...

2026年01月07日 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 上证公告（基金）【2026】24号 为促进华宝沪深300自由现金流交易型开放式指数证券投资基金（以下简称自由现金，基金代 码:562080）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意东海证券股份有限公司自2026年01月08日起为自由现金提供主 做市服务。 特此公告。 上海证券交易所 ...

特此公告。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 上证公告（基金）【2026】25号 为促进易方达上证科创板50成份交易型开放式指数证券投资基金（以下简称科创板50，基金代 码:588080）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意东海证券股份有限公司自2026年01月08日起为科创板50提供主 做市服务。 上海证券交易所 2026年01月07日 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 特此公告。 上海证券交易所 2026年01月07日 上证公告（基金）【2026】21号 为促进华宝中证电子50交易型开放式指数证券投资基金（以下简称电子ETF，基金代码:515260） 的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上市基金做市 业务》等相关规定，本所同意东海证券股份有限公司自2026年01月08日起为电子ETF提供主做市服务。 ...

Market Overview - On January 7, Hong Kong's major stock indices showed a downward trend, with the Hang Seng Index closing at 26,458.95 points, down 0.94% [1] - The Hang Seng Tech Index also ended its previous week's gains, falling 1.49% to 5,738.52 points [1] - The market turnover exceeded HKD 276 billion, ending the upward momentum of the three major indices from the previous trading day [1] Sector Performance - The biopharmaceutical sector showed significant activity towards the end of the trading session, with notable gains in several stocks [1] - Rongchang Biopharmaceutical (09995.HK) rose over 12%, while 3SBio (01530.HK) and WuXi Biologics (02269.HK) closed with gains of over 7% and 5%, respectively [1] - Other sectors such as paper, non-ferrous metals, and coal also saw some individual stocks increase in value [1] Brokerages - In contrast, brokerage stocks faced pressure, with Guotai Junan International (01788.HK) declining over 5% [1] - Both China Merchants Securities (06099.HK) and Everbright Securities (06178.HK) also experienced declines of over 2% [1]

Core Viewpoint - Aoya Co., Ltd. (300949.SZ) experienced a stock price decline, closing at 38.66 yuan, with a drop of 2.82% [1] Group 1: Company Overview - Aoya Co., Ltd. was listed on the Shenzhen Stock Exchange's ChiNext board on February 26, 2021, with an initial public offering (IPO) of 15 million shares at a price of 54.23 yuan per share [1] - The highest price recorded for Aoya's stock since its listing was 143.00 yuan on the first trading day, indicating a significant initial market interest [1] - Currently, Aoya's stock is in a state of decline, having fallen below its IPO price [1] Group 2: Financial Details - The total funds raised from the IPO amounted to 813.45 million yuan, with a net amount of 714.59 million yuan after expenses [1] - The final net amount raised exceeded the original plan by 11.27 million yuan, as the company initially aimed to raise 703.32 million yuan [1] - The IPO expenses (excluding VAT) totaled 98.86 million yuan, with underwriting and sponsorship fees accounting for 81.35 million yuan [1] Group 3: Planned Use of Funds - Aoya Co., Ltd. plans to utilize the raised funds for the construction of a design service network in Shenzhen, expansion of its technology research and development center, and the establishment of an information and collaboration platform [1]

Market Performance - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.94% to 26,458.95 points, the Hang Seng Tech Index down by 1.49% to 5,738.52 points, and the National Enterprises Index decreasing by 1.14% to 9,138.75 points [1] - Major technology stocks dragged the market down, with Alibaba dropping by 3.25%, Tencent by 1.26%, and JD.com by 1.3% [1] - The brokerage sector showed weakness, with Guotai Junan International falling over 5% and both China Merchants Securities and Everbright Securities down over 2% [1] - Oil stocks also declined, with CNOOC dropping over 3% [1] - The automotive sector saw significant declines, particularly for BYD, NIO, and Xpeng [1] - Conversely, the paper industry led gains, with Nine Dragons Paper rising by 12% to reach a new high [1] - The pharmaceutical sector saw late gains, with Rongchang Bio up over 12%, and 3SBio up over 7% [1] - Other sectors such as solar, coal, and dining stocks also experienced increases [1] Company Updates - Yadea Holdings (01585.HK) expects a net profit of no less than RMB 2.9 billion for 2025, up from RMB 1.27 billion in the previous year, driven by increased sales of electric two-wheelers and optimized product structure [2] - Poly Real Estate Group (00119.HK) anticipates a cumulative contract sales amount of approximately RMB 50.2 billion for 2025, a decrease of 7.38% year-on-year [3] - Sunac China (01918.HK) projects a cumulative contract sales amount of about RMB 36.84 billion for 2025, down 21.85% year-on-year [4] - Gemdale Corporation (00535.HK) expects a cumulative contract sales total of approximately RMB 10.696 billion for 2025, a decrease of 47.33% year-on-year [5] - Greentown Management Holdings (09979.HK) estimates new project management fees for 2025 to be RMB 9.35 billion, a year-on-year increase of about 0.4% [6] - Yuexiu Property (00123.HK) has acquired a land parcel in Shanghai's Pudong New Area for RMB 2.561 billion [7] - Jiufang Zhitu Holdings (09636.HK) has completed the acquisition of 100% of JF Financial and its core information systems [8] - Weimob Group (02013.HK) is collaborating with Taobao Flash Sale to create an integrated local retail solution [8] - Dali Pu Holdings (01921.HK) has officially become a qualified supplier for Saudi Aramco [9] - Xiehe New Energy (00182.HK) successfully completed a secondary listing on the Singapore Stock Exchange [10] - Bokan Vision Cloud-B (02592.HK) submitted a clinical trial application for the new drug CBT-009 [11] - Yingtong Holdings (06883.HK) has established a partnership with the Italian high-end fragrance brand CULTI to strengthen its distribution network in China [11] Institutional Insights - CITIC Securities suggests that Hong Kong stocks may see a second round of valuation recovery and performance revival in 2026, recommending focus on technology, healthcare, resource products, consumer staples, paper, and aviation sectors [12] - Everbright Securities indicates that domestic policy initiatives combined with a weaker US dollar may lead to continued upward movement in Hong Kong stocks [12] - Dongwu Securities believes that Hong Kong stocks are entering a period of upward fluctuation, emphasizing the importance of dividend stocks as a base [12] - Industrial Securities recommends a bullish stance on Hong Kong stocks, anticipating a spring rally led by the Hang Seng Tech Index [13]